ATC level 3
L01ECancer medicines (antineoplastics), subgroup L01E
- Molecules
- 58
- Subgroups
- 13
ATC L01E (Cancer medicines (antineoplastics), subgroup L01E) is a level 3 group in the anatomical therapeutic chemical classification. The catalogue lists 58 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
- L01EACancer medicines (antineoplastics), subgroup L01E, subgroup L01EA6
- L01EBCancer medicines (antineoplastics), subgroup L01E, subgroup L01EB4
- L01ECCancer medicines (antineoplastics), subgroup L01E, subgroup L01EC4
- L01EDCancer medicines (antineoplastics), subgroup L01E, subgroup L01ED3
- L01EECancer medicines (antineoplastics), subgroup L01E, subgroup L01EE5
- L01EFCancer medicines (antineoplastics), subgroup L01E, subgroup L01EF3
- L01EHCancer medicines (antineoplastics), subgroup L01E, subgroup L01EH3
- L01EJCancer medicines (antineoplastics), subgroup L01E, subgroup L01EJ2
- L01EKCancer medicines (antineoplastics), subgroup L01E, subgroup L01EK3
- L01ELCancer medicines (antineoplastics), subgroup L01E, subgroup L01EL3
- L01EMCancer medicines (antineoplastics), subgroup L01E, subgroup L01EM2
- L01ENCancer medicines (antineoplastics), subgroup L01E, subgroup L01EN3
- L01EXCancer medicines (antineoplastics), subgroup L01E, subgroup L01EX17
Molecules
Molecules with an ATC code under L01E.
- AbemaciclibKinase Inhibitor4 presentations2 brandsL01EF03
- AcalabrutinibOrphanKinase Inhibitor2 presentations2 brandsL01EL02
- AlectinibOrphanKinase Inhibitor1 presentation2 brandsL01ED03
- AlpelisibOrphan7 presentations4 brandsL01EM03
- AsciminibOrphan3 presentations2 brandsL01EA06
- AvapritinibOrphanKinase Inhibitor5 presentations2 brandsL01EX18
- AxitinibKinase Inhibitor2 presentations3 brandsL01EK01
- BinimetinibOrphan1 presentation2 brandsL01EE03
- BosutinibOrphanKinase Inhibitor8 presentations2 brandsL01EA04
- CabozantinibOrphan1 presentation3 brandsL01EX07
- Capivasertib2 presentations2 brandsL01EX27
- CapmatinibOrphanKinase Inhibitor2 presentations2 brandsL01EX17
- CobimetinibOrphanKinase Inhibitor1 presentation2 brandsL01EE02
- CrizotinibOrphanKinase Inhibitor5 presentations2 brandsL01ED01
- DabrafenibOrphanKinase Inhibitor3 presentations3 brandsL01EC02
- DacomitinibOrphan3 presentations2 brandsL01EB07
- DasatinibOrphanKinase Inhibitor18 presentations4 brandsL01EA02
- DuvelisibOrphan2 presentations1 brandL01EM04
- EncorafenibOrphan1 presentation2 brandsL01EC03
- EntrectinibOrphan3 presentations2 brandsL01EX14
- ErdafitinibKinase Inhibitor3 presentations1 brandL01EN01
- ErlotinibKinase Inhibitor3 presentations1 brandL01EB02
- FedratinibOrphan1 presentation2 brandsL01EJ02
- Fruquintinib2 presentations2 brandsL01EK
- FutibatinibOrphanKinase Inhibitor1 presentation2 brandsL01EN04
- GilteritinibOrphan1 presentation2 brandsL01EX13
- IbrutinibOrphanKinase Inhibitor6 presentations2 brandsL01EL01
- ImatinibOrphanKinase Inhibitor5 presentations5 brandsL01EA01
- LapatinibKinase Inhibitor2 presentations2 brandsL01EH01
- LazertinibKinase Inhibitor2 presentations2 brandsL01EB09
- LenvatinibOrphanKinase Inhibitor3 presentations2 brandsL01EX08
- LorlatinibOrphanKinase Inhibitor2 presentations2 brandsL01ED05
- MirdametinibOrphanKinase Inhibitor3 presentations2 brandsL01EE
- NeratinibKinase Inhibitor1 presentation2 brandsL01EH02
- NilotinibOrphanKinase Inhibitor10 presentations5 brandsL01EA03
- NintedanibOrphanKinase Inhibitor4 presentations5 brandsL01EX09
- OsimertinibOrphanKinase Inhibitor2 presentations2 brandsL01EB04
- PalbociclibKinase Inhibitor6 presentations3 brandsL01EF01
- PemigatinibOrphanKinase Inhibitor3 presentations2 brandsL01EN02
- PonatinibOrphanKinase Inhibitor4 presentations2 brandsL01EA05
- PralsetinibOrphanKinase Inhibitor1 presentation1 brandL01EX23
- QuizartinibOrphanKinase Inhibitor2 presentations2 brandsL01EX11
- RegorafenibOrphanKinase Inhibitor1 presentation2 brandsL01EX05
- RepotrectinibOrphanKinase Inhibitor2 presentations2 brandsL01EX28
- RibociclibKinase Inhibitor1 presentation2 brandsL01EF02
- RuxolitinibOrphanJanus Kinase Inhibitor11 presentations6 brandsD11AH09
- SelpercatinibOrphanKinase Inhibitor6 presentations2 brandsL01EX22
- SelumetinibOrphanKinase Inhibitor4 presentations2 brandsL01EE04
- SorafenibOrphanKinase Inhibitor2 presentations3 brandsL01EX02
- SunitinibKinase Inhibitor8 presentations3 brandsL01EX01
- TepotinibOrphanKinase Inhibitor1 presentation2 brandsL01EX21
- TivozanibKinase Inhibitor2 presentations2 brandsL01EK03
- TovorafenibOrphanKinase Inhibitor2 presentations2 brandsL01EC04
- TrametinibOrphan2 brandsL01EE01
- TucatinibOrphanKinase Inhibitor2 presentations2 brandsL01EH03
- VemurafenibOrphanKinase Inhibitor1 presentation2 brandsL01EC01
- VimseltinibOrphanKinase Inhibitor3 presentations2 brandsL01EX
- ZanubrutinibOrphanKinase Inhibitor2 presentations2 brandsL01EL03
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.